| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | collagen binding | 6.82e-05 | 81 | 105 | 5 | GO:0005518 | |
| GeneOntologyMolecularFunction | ferric-chelate reductase (NADPH) activity | 2.71e-04 | 5 | 105 | 2 | GO:0052851 | |
| GeneOntologyMolecularFunction | ferric-chelate reductase activity | 2.71e-04 | 5 | 105 | 2 | GO:0000293 | |
| GeneOntologyMolecularFunction | cupric reductase (NADH) activity | 2.71e-04 | 5 | 105 | 2 | GO:0008823 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 4.78e-04 | 188 | 105 | 6 | GO:0005201 | |
| GeneOntologyMolecularFunction | heparin binding | 5.35e-04 | 192 | 105 | 6 | GO:0008201 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 5.39e-04 | 268 | 105 | 7 | GO:0005539 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on metal ions, NAD or NADP as acceptor | 5.65e-04 | 7 | 105 | 2 | GO:0016723 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DSCAM FGFRL1 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 LRRC4C DSCAML1 PTPRD PTPRF | 4.76e-07 | 313 | 103 | 11 | GO:0098742 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 4.48e-06 | 187 | 103 | 8 | GO:0007156 | |
| GeneOntologyCellularComponent | anchoring collagen complex | 7.76e-05 | 3 | 107 | 2 | GO:0030934 | |
| GeneOntologyCellularComponent | extracellular matrix | COL7A1 FN1 OLFML2B MUC5B ITIH3 CCN4 ANOS1 NID1 COL14A1 USH2A TNXB | 5.41e-04 | 656 | 107 | 11 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL7A1 FN1 OLFML2B MUC5B ITIH3 CCN4 ANOS1 NID1 COL14A1 USH2A TNXB | 5.55e-04 | 658 | 107 | 11 | GO:0030312 |
| GeneOntologyCellularComponent | stereocilia coupling link | 7.12e-04 | 8 | 107 | 2 | GO:0002139 | |
| GeneOntologyCellularComponent | endoplasmic reticulum-Golgi intermediate compartment | 7.97e-04 | 141 | 107 | 5 | GO:0005793 | |
| GeneOntologyCellularComponent | spine apparatus | 9.13e-04 | 9 | 107 | 2 | GO:0097444 | |
| Domain | fn3 | COL7A1 FN1 DSCAM DSCAML1 IGDCC4 ANOS1 PTPRD PTPRF COL14A1 USH2A TNXB | 1.65e-09 | 162 | 104 | 11 | PF00041 |
| Domain | FN3 | COL7A1 FN1 DSCAM DSCAML1 IGDCC4 ANOS1 PTPRD PTPRF COL14A1 USH2A TNXB | 6.70e-09 | 185 | 104 | 11 | SM00060 |
| Domain | FN3 | COL7A1 FN1 DSCAM DSCAML1 IGDCC4 ANOS1 PTPRD PTPRF COL14A1 USH2A TNXB | 1.43e-08 | 199 | 104 | 11 | PS50853 |
| Domain | FN3_dom | COL7A1 FN1 DSCAM DSCAML1 IGDCC4 ANOS1 PTPRD PTPRF COL14A1 USH2A TNXB | 2.38e-08 | 209 | 104 | 11 | IPR003961 |
| Domain | - | COL7A1 FN1 DSCAM PILRB ROR1 FGFRL1 LRRC4C DSCAML1 IGDCC4 ANOS1 CD300LD PTPRD PTPRF COL14A1 USH2A TNXB EPB42 | 1.42e-07 | 663 | 104 | 17 | 2.60.40.10 |
| Domain | Ig-like_fold | COL7A1 FN1 DSCAM PILRB ROR1 FGFRL1 LRRC4C DSCAML1 IGDCC4 ANOS1 CD300LD PTPRD PTPRF COL14A1 USH2A TNXB EPB42 | 3.45e-07 | 706 | 104 | 17 | IPR013783 |
| Domain | Cadherin_tail | 1.84e-06 | 37 | 104 | 5 | PF15974 | |
| Domain | Cadherin_CBD | 1.84e-06 | 37 | 104 | 5 | IPR031904 | |
| Domain | Ig_I-set | 1.11e-05 | 190 | 104 | 8 | IPR013098 | |
| Domain | I-set | 1.11e-05 | 190 | 104 | 8 | PF07679 | |
| Domain | Cadherin_2 | 3.08e-05 | 65 | 104 | 5 | PF08266 | |
| Domain | Cadherin_N | 3.08e-05 | 65 | 104 | 5 | IPR013164 | |
| Domain | IGc2 | 5.09e-05 | 235 | 104 | 8 | SM00408 | |
| Domain | Ig_sub2 | 5.09e-05 | 235 | 104 | 8 | IPR003598 | |
| Domain | VPS13 | 9.18e-05 | 3 | 104 | 2 | IPR026847 | |
| Domain | VPS13_mid_rpt | 9.18e-05 | 3 | 104 | 2 | PF16910 | |
| Domain | VPS13 | 9.18e-05 | 3 | 104 | 2 | PF16908 | |
| Domain | VPS13_N2 | 9.18e-05 | 3 | 104 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 9.18e-05 | 3 | 104 | 2 | IPR031642 | |
| Domain | IG | DSCAM PILRB ROR1 FGFRL1 LRRC4C DSCAML1 IGDCC4 CD300LD PTPRD PTPRF | 1.20e-04 | 421 | 104 | 10 | SM00409 |
| Domain | Ig_sub | DSCAM PILRB ROR1 FGFRL1 LRRC4C DSCAML1 IGDCC4 CD300LD PTPRD PTPRF | 1.20e-04 | 421 | 104 | 10 | IPR003599 |
| Domain | CTCK_1 | 1.29e-04 | 18 | 104 | 3 | PS01185 | |
| Domain | LamGL | 1.83e-04 | 4 | 104 | 2 | SM00560 | |
| Domain | SHR-BD | 1.83e-04 | 4 | 104 | 2 | IPR009543 | |
| Domain | LamG-like | 1.83e-04 | 4 | 104 | 2 | IPR006558 | |
| Domain | VPS13_C | 1.83e-04 | 4 | 104 | 2 | PF16909 | |
| Domain | VPS13_C | 1.83e-04 | 4 | 104 | 2 | IPR031645 | |
| Domain | SHR-BD | 1.83e-04 | 4 | 104 | 2 | PF06650 | |
| Domain | CT | 2.39e-04 | 22 | 104 | 3 | SM00041 | |
| Domain | Cys_knot_C | 3.53e-04 | 25 | 104 | 3 | IPR006207 | |
| Domain | CTCK_2 | 3.53e-04 | 25 | 104 | 3 | PS01225 | |
| Domain | Cadherin_CS | 3.59e-04 | 109 | 104 | 5 | IPR020894 | |
| Domain | IG_LIKE | DSCAM PILRB ROR1 FGFRL1 LRRC4C DSCAML1 IGDCC4 CD300LD PTPRD PTPRF | 4.13e-04 | 491 | 104 | 10 | PS50835 |
| Domain | CADHERIN_1 | 4.24e-04 | 113 | 104 | 5 | PS00232 | |
| Domain | Cadherin | 4.24e-04 | 113 | 104 | 5 | PF00028 | |
| Domain | CADHERIN_2 | 4.41e-04 | 114 | 104 | 5 | PS50268 | |
| Domain | - | 4.41e-04 | 114 | 104 | 5 | 2.60.40.60 | |
| Domain | WxxW_domain | 4.54e-04 | 6 | 104 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 4.54e-04 | 6 | 104 | 2 | PF13330 | |
| Domain | CA | 4.59e-04 | 115 | 104 | 5 | SM00112 | |
| Domain | Cadherin-like | 4.78e-04 | 116 | 104 | 5 | IPR015919 | |
| Domain | Ig-like_dom | DSCAM PILRB ROR1 FGFRL1 LRRC4C DSCAML1 IGDCC4 CD300LD PTPRD PTPRF | 4.98e-04 | 503 | 104 | 10 | IPR007110 |
| Domain | Cadherin | 5.17e-04 | 118 | 104 | 5 | IPR002126 | |
| Domain | Chorein_N | 8.41e-04 | 8 | 104 | 2 | PF12624 | |
| Domain | VPS13_N | 8.41e-04 | 8 | 104 | 2 | IPR026854 | |
| Domain | VWFC_2 | 1.23e-03 | 38 | 104 | 3 | PS50184 | |
| Domain | VWC | 1.23e-03 | 38 | 104 | 3 | SM00214 | |
| Domain | VWF_dom | 1.64e-03 | 42 | 104 | 3 | IPR001007 | |
| Domain | Ferric_reduct | 1.95e-03 | 12 | 104 | 2 | PF01794 | |
| Domain | C8 | 1.95e-03 | 12 | 104 | 2 | PF08742 | |
| Domain | TIL | 1.95e-03 | 12 | 104 | 2 | PF01826 | |
| Domain | Fe3_Rdtase_TM_dom | 1.95e-03 | 12 | 104 | 2 | IPR013130 | |
| Domain | Unchr_dom_Cys-rich | 2.30e-03 | 13 | 104 | 2 | IPR014853 | |
| Domain | C8 | 2.30e-03 | 13 | 104 | 2 | SM00832 | |
| Domain | TIL_dom | 2.68e-03 | 14 | 104 | 2 | IPR002919 | |
| Domain | P_typ_ATPase_c | 2.68e-03 | 14 | 104 | 2 | IPR032630 | |
| Domain | P-type_ATPase_N | 2.68e-03 | 14 | 104 | 2 | IPR032631 | |
| Domain | P-type_ATPase_IV | 2.68e-03 | 14 | 104 | 2 | IPR006539 | |
| Domain | SEA | 2.68e-03 | 14 | 104 | 2 | SM00200 | |
| Domain | PhoLip_ATPase_C | 2.68e-03 | 14 | 104 | 2 | PF16212 | |
| Domain | PhoLip_ATPase_N | 2.68e-03 | 14 | 104 | 2 | PF16209 | |
| Domain | Glyco_hormone_CN | 3.08e-03 | 15 | 104 | 2 | IPR006208 | |
| Domain | Cys_knot | 3.08e-03 | 15 | 104 | 2 | PF00007 | |
| Domain | VWF_type-D | 3.50e-03 | 16 | 104 | 2 | IPR001846 | |
| Domain | VWFD | 3.50e-03 | 16 | 104 | 2 | PS51233 | |
| Domain | VWD | 3.50e-03 | 16 | 104 | 2 | SM00216 | |
| Domain | VWD | 3.50e-03 | 16 | 104 | 2 | PF00094 | |
| Domain | VWA | 3.75e-03 | 56 | 104 | 3 | PF00092 | |
| Domain | RUN | 4.94e-03 | 19 | 104 | 2 | PS50826 | |
| Domain | GOLD_dom | 4.94e-03 | 19 | 104 | 2 | IPR009038 | |
| Domain | VWC_out | 4.94e-03 | 19 | 104 | 2 | SM00215 | |
| Domain | RUN | 4.94e-03 | 19 | 104 | 2 | PF02759 | |
| Domain | Run_dom | 4.94e-03 | 19 | 104 | 2 | IPR004012 | |
| Domain | GOLD | 4.94e-03 | 19 | 104 | 2 | PS50866 | |
| Domain | Ig_V-set | 5.13e-03 | 199 | 104 | 5 | IPR013106 | |
| Pubmed | 7.70e-10 | 15 | 108 | 5 | 15640798 | ||
| Pubmed | 1.06e-09 | 101 | 108 | 8 | 18519826 | ||
| Pubmed | 1.58e-09 | 17 | 108 | 5 | 29911975 | ||
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | 2.18e-09 | 18 | 108 | 5 | 15570159 | |
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | 2.18e-09 | 18 | 108 | 5 | 10662547 | |
| Pubmed | 1.07e-08 | 24 | 108 | 5 | 24698270 | ||
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 2.44e-08 | 28 | 108 | 5 | 15347688 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | FN1 HCN1 ROR1 MUC19 PCDHA5 HUWE1 TMEM132B DSCAML1 ITPR2 SLC6A6 CCN4 WIZ RPAP1 VPS13A | 7.14e-08 | 736 | 108 | 14 | 29676528 |
| Pubmed | 2.17e-07 | 134 | 108 | 7 | 24324551 | ||
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 19110483 | ||
| Pubmed | 7.85e-07 | 162 | 108 | 7 | 25826454 | ||
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 9.68e-07 | 57 | 108 | 5 | 32633719 | |
| Pubmed | alpha3beta1 Integrin is required for normal development of the epidermal basement membrane. | 1.01e-06 | 7 | 108 | 3 | 9151677 | |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | 1.06e-06 | 58 | 108 | 5 | 30377227 | |
| Pubmed | Quantitative Trait Loci and a Novel Genetic Candidate for Fear Learning. | 1.61e-06 | 8 | 108 | 3 | 27277803 | |
| Pubmed | 1.73e-06 | 64 | 108 | 5 | 22261194 | ||
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 2.35e-06 | 68 | 108 | 5 | 11230163 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 3.12e-06 | 72 | 108 | 5 | 10380929 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 3.57e-06 | 74 | 108 | 5 | 10817752 | |
| Pubmed | The DNA sequence and comparative analysis of human chromosome 5. | 3.82e-06 | 75 | 108 | 5 | 15372022 | |
| Pubmed | 4.35e-06 | 77 | 108 | 5 | 10835267 | ||
| Pubmed | 4.72e-06 | 11 | 108 | 3 | 7832766 | ||
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | 4.72e-06 | 11 | 108 | 3 | 9655502 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 5.25e-06 | 80 | 108 | 5 | 10716726 | |
| Pubmed | Proteins of the CNR family are multiple receptors for Reelin. | 6.28e-06 | 12 | 108 | 3 | 10612399 | |
| Pubmed | Oligomerization of MrgC11 and μ-opioid receptors in sensory neurons enhances morphine analgesia. | 9.55e-06 | 2 | 108 | 2 | 29921657 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 7963647 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 37209327 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 21645617 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 25451118 | ||
| Pubmed | ES cell-derived renewable and functional midbrain dopaminergic progenitors. | 9.55e-06 | 2 | 108 | 2 | 21606375 | |
| Pubmed | Mammalian DSCAMs: roles in the development of the spinal cord, cortex, and cerebellum? | 9.55e-06 | 2 | 108 | 2 | 12051741 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 7665159 | ||
| Pubmed | Mast-cell-specific receptor mediates alcohol-withdrawal-associated headache in male mice. | 9.55e-06 | 2 | 108 | 2 | 37909038 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 33141174 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.30e-05 | 248 | 108 | 7 | 24006456 | |
| Pubmed | 1.58e-05 | 16 | 108 | 3 | 11564885 | ||
| Pubmed | 1.64e-05 | 101 | 108 | 5 | 10997877 | ||
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 2.30e-05 | 18 | 108 | 3 | 18834073 | |
| Pubmed | 2.84e-05 | 503 | 108 | 9 | 36217030 | ||
| Pubmed | Expression of tenascin in developing and adult mouse lymphoid organs. | 2.86e-05 | 3 | 108 | 2 | 7687262 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 20610895 | ||
| Pubmed | PACAP38/mast-cell-specific receptor axis mediates repetitive stress-induced headache in mice. | 2.86e-05 | 3 | 108 | 2 | 38802819 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 27230679 | ||
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 2.86e-05 | 3 | 108 | 2 | 31985401 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 23986473 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 20139422 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 25703008 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 30841425 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 9784606 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 11479226 | ||
| Pubmed | Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR. | 2.86e-05 | 3 | 108 | 2 | 33656439 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 26057585 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 19196137 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 27637097 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 9278415 | ||
| Pubmed | 3.17e-05 | 285 | 108 | 7 | 32838362 | ||
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | 3.63e-05 | 119 | 108 | 5 | 28625976 | |
| Pubmed | 4.30e-05 | 22 | 108 | 3 | 27527664 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 11419941 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 15522896 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 15498460 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 31027996 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 8524829 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 12880872 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 6.62e-05 | 135 | 108 | 5 | 28675934 | |
| Pubmed | 7.19e-05 | 26 | 108 | 3 | 36178190 | ||
| Pubmed | Gene expression in the developing mouse retina by EST sequencing and microarray analysis. | 8.41e-05 | 142 | 108 | 5 | 11812828 | |
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 16609065 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 10777529 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 22357843 | ||
| Pubmed | Hippocampal short- and long-term plasticity are not modulated by astrocyte Ca2+ signaling. | 9.50e-05 | 5 | 108 | 2 | 20203048 | |
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 11493006 | ||
| Pubmed | House dust mites activate nociceptor-mast cell clusters to drive type 2 skin inflammation. | 9.50e-05 | 5 | 108 | 2 | 31591569 | |
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 9647658 | ||
| Pubmed | Astrocytes modulate neural network activity by Ca²+-dependent uptake of extracellular K+. | 9.50e-05 | 5 | 108 | 2 | 22472648 | |
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 9169408 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 12429817 | ||
| Pubmed | 9.78e-05 | 591 | 108 | 9 | 15231748 | ||
| Pubmed | 1.19e-04 | 153 | 108 | 5 | 25037231 | ||
| Pubmed | 1.42e-04 | 6 | 108 | 2 | 19273906 | ||
| Pubmed | 1.42e-04 | 6 | 108 | 2 | 11956183 | ||
| Pubmed | 1.42e-04 | 6 | 108 | 2 | 20874775 | ||
| Pubmed | 1.57e-04 | 493 | 108 | 8 | 15368895 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 HIVEP2 FGFRL1 FYCO1 CFAP43 HUWE1 ITPR2 C2CD3 AATK WIZ RPAP1 PTPRF | 1.69e-04 | 1105 | 108 | 12 | 35748872 |
| Pubmed | 1.80e-04 | 167 | 108 | 5 | 22159717 | ||
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 29073098 | ||
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 12376545 | ||
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 9136115 | ||
| Pubmed | CDC50 proteins are critical components of the human class-1 P4-ATPase transport machinery. | 1.99e-04 | 7 | 108 | 2 | 20961850 | |
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 20947505 | ||
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 1.99e-04 | 7 | 108 | 2 | 10716744 | |
| Pubmed | Integrins are required for the differentiation of visceral endoderm. | 1.99e-04 | 7 | 108 | 2 | 19118216 | |
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 9501082 | ||
| Pubmed | 2.23e-04 | 175 | 108 | 5 | 28071719 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | ERP44 UGGT1 CD109 XPO1 HUWE1 SHKBP1 PTPRD RPAP1 PTPRF NID1 DIAPH3 | 2.29e-04 | 974 | 108 | 11 | 28675297 |
| Pubmed | 2.45e-04 | 39 | 108 | 3 | 33580754 | ||
| Pubmed | Genome-wide association study of primary dentition pit-and-fissure and smooth surface caries. | 2.45e-04 | 39 | 108 | 3 | 24556642 | |
| Pubmed | Npa3 interacts with Gpn3 and assembly factor Rba50 for RNA polymerase II biogenesis. | 2.64e-04 | 8 | 108 | 2 | 32985767 | |
| Pubmed | 2.64e-04 | 8 | 108 | 2 | 11847210 | ||
| Interaction | PCDHA10 interactions | 7.04e-08 | 22 | 101 | 5 | int:PCDHA10 | |
| Interaction | PCDHA8 interactions | 8.16e-06 | 55 | 101 | 5 | int:PCDHA8 | |
| Cytoband | 5q31 | 8.20e-06 | 115 | 108 | 5 | 5q31 | |
| GeneFamily | Fibronectin type III domain containing | COL7A1 FN1 DSCAM DSCAML1 IGDCC4 ANOS1 PTPRD PTPRF PTPRQ COL14A1 USH2A TNXB | 3.40e-12 | 160 | 77 | 12 | 555 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.15e-07 | 161 | 77 | 8 | 593 | |
| GeneFamily | CD molecules|Mucins | 1.72e-06 | 21 | 77 | 4 | 648 | |
| GeneFamily | Clustered protocadherins | 7.70e-06 | 64 | 77 | 5 | 20 | |
| GeneFamily | ATP binding cassette subfamily D|GOLD domain containing | 5.36e-05 | 3 | 77 | 2 | 1062 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 9.35e-05 | 21 | 77 | 3 | 813 | |
| GeneFamily | Proteases, serine|STEAP family | 1.78e-04 | 5 | 77 | 2 | 1324 | |
| GeneFamily | ATPase phospholipid transporting | 1.81e-03 | 15 | 77 | 2 | 1210 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 7.45e-03 | 181 | 77 | 4 | 694 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 1.45e-05 | 352 | 107 | 9 | M17471 | |
| Coexpression | NABA_CORE_MATRISOME | 1.76e-05 | 275 | 107 | 8 | M5884 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_3_PRECICTIVE_ICB_RESPONSE | 2.62e-05 | 211 | 107 | 7 | MM17081 | |
| Coexpression | HOLLERN_MICROACINAR_BREAST_TUMOR_DN | 3.56e-05 | 16 | 107 | 3 | MM969 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 4.94e-09 | 159 | 107 | 8 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.74e-09 | 171 | 107 | 8 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-08 | 184 | 107 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-08 | 184 | 107 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-08 | 184 | 107 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.64e-08 | 197 | 107 | 8 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-4|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.96e-08 | 200 | 107 | 8 | 54b18c92daaa3b3368c0c46134b0c27e10c8dbb0 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 2.96e-08 | 200 | 107 | 8 | c2c6f687c49ba790174b27c7b8b084af30b34c86 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.52e-07 | 178 | 107 | 7 | 536a601abcc60867949ea06e9aafb6c7b799b56b | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|tumor_Lung / Location, Cell class and cell subclass | 3.15e-07 | 184 | 107 | 7 | b0a251030d127858e68cf164be158f209a4d720f | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.39e-07 | 186 | 107 | 7 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.91e-07 | 190 | 107 | 7 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-07 | 192 | 107 | 7 | 38d7a24ae205ef91ed2e0f402d8022f2a9cdb243 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-07 | 192 | 107 | 7 | 04d155897ed075c359933080e36a4ab2150b6e9f | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-07 | 192 | 107 | 7 | 84149a5c6c3b3c9b86aed77cf8e72d99ef099fab | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.66e-07 | 195 | 107 | 7 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.66e-07 | 195 | 107 | 7 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | distal-mesenchymal-Lipofibroblast-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.00e-07 | 197 | 107 | 7 | 865010edcd7e3f79f505fcef7b33882095994aa8 | |
| ToppCell | distal-mesenchymal-Lipofibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.00e-07 | 197 | 107 | 7 | ceb83bdef16b58ee16193413bfb006f7715728b2 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.00e-07 | 197 | 107 | 7 | 31c8d6e565bbdc37843ce871fe91845b0cc18a9f | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 5.17e-07 | 198 | 107 | 7 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | metastatic_Brain-Fibroblasts-FB-like_cells|metastatic_Brain / Location, Cell class and cell subclass | 5.35e-07 | 199 | 107 | 7 | 12133087eae9f0e9b6c13a71e8187117768e64ce | |
| ToppCell | distal-1-mesenchymal-Lipofibroblast|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.35e-07 | 199 | 107 | 7 | a8293db3c42a8d30897858b49aae7acfc18663ba | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.53e-07 | 200 | 107 | 7 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-06 | 160 | 107 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-06 | 160 | 107 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 2.75e-06 | 163 | 107 | 6 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | AT1-AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 3.39e-06 | 169 | 107 | 6 | 815474855a70498a74e52f6583113c63b7267a0c | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.39e-06 | 169 | 107 | 6 | 335619507857383c3b0b507cdf05d786ed59e585 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.63e-06 | 171 | 107 | 6 | 74be8d3bf6b99e2d734635a8b1a7c41e8c596959 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.63e-06 | 171 | 107 | 6 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 4.29e-06 | 176 | 107 | 6 | bfa1633e1b7a8a2f04d37fa07284fe9bc0199f46 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.43e-06 | 177 | 107 | 6 | 3d955ea938a1d2fb1b6d68d4997fd454bd632dfc | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.57e-06 | 178 | 107 | 6 | 9d575902d3dbe33437c9d4200df093a741269803 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.57e-06 | 178 | 107 | 6 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.72e-06 | 179 | 107 | 6 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.72e-06 | 179 | 107 | 6 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.88e-06 | 180 | 107 | 6 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.88e-06 | 180 | 107 | 6 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.03e-06 | 181 | 107 | 6 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-06 | 182 | 107 | 6 | 6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.36e-06 | 183 | 107 | 6 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.36e-06 | 183 | 107 | 6 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.36e-06 | 183 | 107 | 6 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.53e-06 | 184 | 107 | 6 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.53e-06 | 184 | 107 | 6 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.71e-06 | 185 | 107 | 6 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 5.71e-06 | 185 | 107 | 6 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.89e-06 | 186 | 107 | 6 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.89e-06 | 186 | 107 | 6 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.89e-06 | 186 | 107 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.89e-06 | 186 | 107 | 6 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 5.89e-06 | 186 | 107 | 6 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.07e-06 | 187 | 107 | 6 | f1d0fc625e0e7881b3f290742fd7148d995eb71e | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.07e-06 | 187 | 107 | 6 | 02e7246ef5ad41773d14426254e139b156d45c1d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.07e-06 | 187 | 107 | 6 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.07e-06 | 187 | 107 | 6 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.07e-06 | 187 | 107 | 6 | 08c73d125e0638c9e9878165bba2442c266c8a48 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 6.07e-06 | 187 | 107 | 6 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 6.07e-06 | 187 | 107 | 6 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.65e-06 | 190 | 107 | 6 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.65e-06 | 190 | 107 | 6 | 947807863a9b247c301c6cf63d6fd5a2c8018e66 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.85e-06 | 191 | 107 | 6 | b51e0f5d1b93f526160c904e9091313a5364f3a7 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.85e-06 | 191 | 107 | 6 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.85e-06 | 191 | 107 | 6 | db4943dd19207663fb9e27f8940fa4b06a933625 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.06e-06 | 192 | 107 | 6 | 30cefa0990ba1f379f350bfbf994a78db145075e | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-06 | 192 | 107 | 6 | 853a930e0641ffb50cbb4cef5837c70d75c3fc39 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.06e-06 | 192 | 107 | 6 | dc4b4e16e6eb212e45fb70695afd1c7e91027407 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.06e-06 | 192 | 107 | 6 | 2cc712186e37fb21a964c032765c36a8b4a852cf | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 7.06e-06 | 192 | 107 | 6 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-06 | 192 | 107 | 6 | 49281626ecad0456fdbded2378b7028d7b589686 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.06e-06 | 192 | 107 | 6 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-06 | 193 | 107 | 6 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-06 | 193 | 107 | 6 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.49e-06 | 194 | 107 | 6 | c992e3357f4bf3069f8d697803e5785e49a2ef0a | |
| ToppCell | P28-Mesenchymal-myocytic_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.49e-06 | 194 | 107 | 6 | 83e45441c74b7f50b6725876b583229280179dc2 | |
| ToppCell | RA|World / Chamber and Cluster_Paper | 7.49e-06 | 194 | 107 | 6 | 08f0afbb68a63150fbe107a5337299081c3f69e4 | |
| ToppCell | P28-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.49e-06 | 194 | 107 | 6 | 3c661c6768c3f05d2aba03d329adb257ca201b2d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.49e-06 | 194 | 107 | 6 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | P15-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.49e-06 | 194 | 107 | 6 | 5f04d21c4e2d36e74b6c5889aa97fd98f75a0973 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.71e-06 | 195 | 107 | 6 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | Parenchymal-NucSeq-Stromal-Mesofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.71e-06 | 195 | 107 | 6 | a52685f76eca269a7d2de8dfc317439483e233fa | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.71e-06 | 195 | 107 | 6 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Mesofibroblastic-Mesothelia|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.71e-06 | 195 | 107 | 6 | 224deeba2f60def6543a55bb4f5ee6c7fdab3f02 | |
| ToppCell | 15-Trachea-Mesenchymal|Trachea / Age, Tissue, Lineage and Cell class | 7.94e-06 | 196 | 107 | 6 | 7e178c76285e61c721c38d7a995ebf89dc428f9f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts-Subpleural_fibroblasts_L.2.1.5.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.94e-06 | 196 | 107 | 6 | 46d665de09f8164690b9a3e0acf0b0afa3f81b3d | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | 7.94e-06 | 196 | 107 | 6 | 54aefcebf13704f51de84379e2e22ec0734b9461 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.17e-06 | 197 | 107 | 6 | 6e111ba16fc8adde782b3f7da250248cddf11228 | |
| ToppCell | PND03-Mesenchymal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.17e-06 | 197 | 107 | 6 | e3053ef8f604b6892c21c03e12612b49d3d30f23 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.17e-06 | 197 | 107 | 6 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.17e-06 | 197 | 107 | 6 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.17e-06 | 197 | 107 | 6 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.17e-06 | 197 | 107 | 6 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.17e-06 | 197 | 107 | 6 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 8.17e-06 | 197 | 107 | 6 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 8.17e-06 | 197 | 107 | 6 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.41e-06 | 198 | 107 | 6 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.41e-06 | 198 | 107 | 6 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.41e-06 | 198 | 107 | 6 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | distal-mesenchymal-Mesothelial-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.41e-06 | 198 | 107 | 6 | 431bf719ee5cce4c9e8b6b405819b67e98fad3ca | |
| Computational | Adhesion molecules. | 8.67e-05 | 141 | 56 | 6 | MODULE_122 | |
| Disease | 1,5 anhydroglucitol measurement | 5.75e-08 | 29 | 105 | 5 | EFO_0008009 | |
| Disease | post-traumatic stress disorder symptom measurement | 4.94e-07 | 82 | 105 | 6 | EFO_0008535 | |
| Disease | Abnormality of refraction | DSCAM HCN1 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 LRRC4C DSCAML1 ITPR2 OTX2 PTPRF FAM124A | 8.22e-07 | 673 | 105 | 13 | HP_0000539 |
| Disease | neutrophil count | HIVEP2 DSCAM NUP210L OLFML2B PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 XPO1 ITPR2 TBX19 AATK FAM186A CNKSR3 AKAP11 STEAP1B TNXB | 1.75e-06 | 1382 | 105 | 18 | EFO_0004833 |
| Disease | post-traumatic stress disorder | 8.20e-06 | 202 | 105 | 7 | EFO_0001358 | |
| Disease | visceral adipose tissue measurement, body mass index | 1.52e-05 | 87 | 105 | 5 | EFO_0004340, EFO_0004765 | |
| Disease | opioid dependence | 2.30e-05 | 237 | 105 | 7 | EFO_0005611 | |
| Disease | neuroticism measurement, cognitive function measurement | DSCAM NUP210L HCN1 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 AATK CSMD1 | 3.52e-05 | 566 | 105 | 10 | EFO_0007660, EFO_0008354 |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 3.75e-05 | 3 | 105 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | depressive symptom measurement | 1.45e-04 | 426 | 105 | 8 | EFO_0007006 | |
| Disease | cerebrospinal fluid clusterin measurement | 2.64e-04 | 35 | 105 | 3 | EFO_0007657 | |
| Disease | parasitemia measurement | 3.12e-04 | 37 | 105 | 3 | EFO_0005528 | |
| Disease | age at first sexual intercourse measurement | 4.50e-04 | 383 | 105 | 7 | EFO_0009749 | |
| Disease | neurotic disorder | 4.74e-04 | 101 | 105 | 4 | EFO_0004257 | |
| Disease | cleft lip | 5.47e-04 | 284 | 105 | 6 | EFO_0003959 | |
| Disease | chronic obstructive pulmonary disease, chronic bronchitis | 5.54e-04 | 10 | 105 | 2 | EFO_0000341, EFO_0006505 | |
| Disease | serum IgG glycosylation measurement | 5.73e-04 | 523 | 105 | 8 | EFO_0005193 | |
| Disease | testosterone measurement | VRK2 VGLL3 DSCAM FGFRL1 OPRM1 GPR180 TBX19 PTPRF FAM186A PGAP1 CNKSR3 MED23 USH2A | 6.00e-04 | 1275 | 105 | 13 | EFO_0004908 |
| Disease | pneumococcal bacteremia | 6.76e-04 | 11 | 105 | 2 | EFO_1001925 | |
| Disease | nucleus accumbens volume change measurement | 6.76e-04 | 11 | 105 | 2 | EFO_0021493 | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 7.59e-04 | 200 | 105 | 5 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder | 8.05e-04 | 51 | 105 | 3 | EFO_0003756, EFO_0003888, MONDO_0002009, MONDO_0004985, MONDO_0005090 | |
| Disease | triacylglycerol 44:1 measurement | 8.09e-04 | 12 | 105 | 2 | EFO_0010399 | |
| Disease | wellbeing measurement | 8.28e-04 | 692 | 105 | 9 | EFO_0007869 | |
| Disease | smoking status measurement, ulcerative colitis | 9.54e-04 | 13 | 105 | 2 | EFO_0000729, EFO_0006527 | |
| Disease | cortical surface area measurement | TANC2 VRK2 ROR1 FGFRL1 XPO1 RFX4 PTPRF CNKSR3 PAPPA DIAPH3 MED23 STEAP1B TNXB | 9.82e-04 | 1345 | 105 | 13 | EFO_0010736 |
| Disease | tuberculosis | 1.07e-03 | 216 | 105 | 5 | MONDO_0018076 | |
| Disease | glycodeoxycholate measurement | 1.11e-03 | 14 | 105 | 2 | EFO_0010493 | |
| Disease | 3-hydroxyphenylacetic acid measurement | 1.11e-03 | 14 | 105 | 2 | EFO_0010448 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.11e-03 | 447 | 105 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | autism spectrum disorder, schizophrenia | 1.14e-03 | 327 | 105 | 6 | EFO_0003756, MONDO_0005090 | |
| Disease | anxiety | 1.23e-03 | 223 | 105 | 5 | EFO_0005230 | |
| Disease | neutrophil count, basophil count | 1.26e-03 | 224 | 105 | 5 | EFO_0004833, EFO_0005090 | |
| Disease | Down syndrome (implicated_via_orthology) | 1.28e-03 | 15 | 105 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | vital capacity | VRK2 HIVEP2 FN1 POM121L2 PCDHA7 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PTPRD DIAPH3 TNXB | 1.49e-03 | 1236 | 105 | 12 | EFO_0004312 |
| Disease | Bipolar Disorder | 1.61e-03 | 477 | 105 | 7 | C0005586 | |
| Disease | urate measurement, bone density | 1.68e-03 | 619 | 105 | 8 | EFO_0003923, EFO_0004531 | |
| Disease | cognitive function measurement | TANC2 VRK2 DSCAM NUP210L POM121L2 LMBRD2 CEMIP PTPRD PTPRF CNKSR3 DIAPH3 USH2A TNXB | 1.74e-03 | 1434 | 105 | 13 | EFO_0008354 |
| Disease | Alcohol abuse | 1.78e-03 | 67 | 105 | 3 | C0085762 | |
| Disease | parental longevity | 1.96e-03 | 494 | 105 | 7 | EFO_0007796 | |
| Disease | age at onset, smoking initiation | 2.06e-03 | 19 | 105 | 2 | EFO_0004847, EFO_0005670 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 2.10e-03 | 71 | 105 | 3 | EFO_0007878, EFO_0007979 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.16e-03 | 152 | 105 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | gestational age, birth measurement | 2.52e-03 | 21 | 105 | 2 | EFO_0005112, EFO_0006921 | |
| Disease | Alcoholic Intoxication, Chronic | 2.75e-03 | 268 | 105 | 5 | C0001973 | |
| Disease | triacylglycerol 58:9 measurement | 2.77e-03 | 22 | 105 | 2 | EFO_0010443 | |
| Disease | arginine measurement | 3.02e-03 | 23 | 105 | 2 | EFO_0020990 | |
| Disease | birth weight | 3.08e-03 | 399 | 105 | 6 | EFO_0004344 | |
| Disease | airway responsiveness measurement | 3.29e-03 | 24 | 105 | 2 | EFO_0006897 | |
| Disease | Sjogren's syndrome (is_marker_for) | 3.29e-03 | 24 | 105 | 2 | DOID:12894 (is_marker_for) | |
| Disease | brain stem volume measurement | 3.29e-03 | 24 | 105 | 2 | EFO_0010605 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VSWGSRTCSTTTPAV | 231 | Q6GPI1 | |
| SWTISVTTPADAVIG | 101 | P16452 | |
| CLSSPSTVSVWTIER | 171 | Q8NDM7 | |
| PGTQTAVSEWTTTTA | 126 | Q6UXZ3 | |
| AVSEWTTTTASLAFT | 131 | Q6UXZ3 | |
| IVSTGSILTLWFTTD | 111 | Q96PZ7 | |
| TAAGTVPWFTVEKTS | 441 | Q8IZF6 | |
| ATVSSPISSFFETTW | 2206 | Q8IZF6 | |
| FETTWLDSTPSFLST | 2216 | Q8IZF6 | |
| EASASATTLLPVSWV | 126 | C9JDP6 | |
| TSVTTSISEPWTQRS | 266 | Q9UKA4 | |
| EISSLTWFTTIVPLV | 71 | Q8TF62 | |
| PWTLAAVTAAAASTV | 6 | O95388 | |
| STIQWSVSRTPTISL | 296 | Q9ULG3 | |
| VSLTSNPVSWVESFG | 201 | Q9NSV4 | |
| TISWLTLTCFPGATS | 16 | Q8WUJ3 | |
| QISSLSWFTTIVPLV | 91 | P98198 | |
| TATPLSSSAVLVAWE | 436 | Q8TDY8 | |
| TPTQTTATEKTTLWV | 1456 | Q9HC84 | |
| TTLWVTPSIRSTAAL | 1466 | Q9HC84 | |
| GTTWILTELTTTATT | 2431 | Q9HC84 | |
| TTWILTEPSTTATVT | 2461 | Q9HC84 | |
| GTTWTRLSQTTTPTA | 2546 | Q9HC84 | |
| TPGTTWILTEQTTAA | 2986 | Q9HC84 | |
| SSTPGTTWILTELTT | 3126 | Q9HC84 | |
| TWILTEPSTTATVTV | 3161 | Q9HC84 | |
| SVTAIPSSSLGTAWT | 3236 | Q9HC84 | |
| GTAWTRLSQTTTPTA | 3246 | Q9HC84 | |
| TPGTTWILTKLTTTA | 3686 | Q9HC84 | |
| SLGTTWTRLSQTTTP | 3801 | Q9HC84 | |
| SSTPGTTWILTELTT | 4241 | Q9HC84 | |
| PGTTWILTELTTAAT | 4386 | Q9HC84 | |
| GTTWILTELTTTATT | 4416 | Q9HC84 | |
| TTWILTEPSTTATVT | 4446 | Q9HC84 | |
| GTTWTRLSQTTTPTA | 4531 | Q9HC84 | |
| ATLSSTPGTTWILTE | 4836 | Q9HC84 | |
| TWSLTYTVTTAAGSP | 551 | Q33E94 | |
| HLCTNTWVTSTSIPI | 391 | Q14571 | |
| GSPSLWATTSVSIEV | 431 | Q9Y5H9 | |
| ITATTSPESRGCTLW | 396 | Q8N1W1 | |
| GSPSLWATASVSVEV | 431 | Q9UN72 | |
| IGFTSSLISVWVISS | 151 | Q8N0Y5 | |
| STVNSDGSVTVTIVW | 301 | P23352 | |
| LTSPATKAWTITDTT | 1376 | Q8WXI7 | |
| TIVWTSTGTIEQSTQ | 1971 | Q8WXI7 | |
| ETWVSTTAIPSTVLN | 3391 | Q8WXI7 | |
| ASWTGTPLATTQRFT | 4116 | Q8WXI7 | |
| QSTISPDISTRTVSW | 7876 | Q8WXI7 | |
| PDISTRTVSWFSTSP | 7881 | Q8WXI7 | |
| ALVTIPETTFQTVSW | 306 | P35372 | |
| GSPSLWATASVSVEV | 431 | Q9Y5H8 | |
| WTGSVPIFSVSSAIT | 101 | P48060 | |
| LTISWVFSSDPKSIS | 1386 | Q9BQS8 | |
| LTLPNFIFWTTISTT | 156 | P25089 | |
| PTVSRVTTEASWASL | 466 | Q86V42 | |
| VPWYSEACASTLTTT | 331 | Q6UW60 | |
| VASSSSATSLPWPVV | 366 | Q8N441 | |
| TTRPLVTESWTAGTS | 3106 | Q7Z5P9 | |
| IRGEETATWISSPSV | 756 | Q9Y233 | |
| SFQPSSAVVVTWESV | 146 | P14543 | |
| VDFWTSTIPLILSAS | 536 | Q6NT32 | |
| TVSVLIGSFALSWTP | 226 | Q8TDV5 | |
| VISSPSLTSETEWVG | 1171 | Q9ULK4 | |
| VVDWETTNVTTSLTP | 481 | Q9HCJ2 | |
| CFIPTLITTTSWESF | 61 | A6NDL7 | |
| WEVSSLSSVTLPLTI | 416 | Q86V85 | |
| ITSWVSGFISSPVQT | 146 | Q13607 | |
| LVPESLTIWVTFVST | 791 | Q13219 | |
| SPSLWATASVSVEVA | 431 | Q9Y5H7 | |
| PLTTSDTKTVSEWIS | 1501 | Q7Z6Z7 | |
| ASVWPSLPSSTELTT | 321 | Q9BQQ3 | |
| TWSASGTIITEALAS | 131 | Q9HCN4 | |
| STFSSTTLGPIFWLL | 246 | Q8NBN7 | |
| SDVQSTSATLTWIRP | 1481 | Q9UMZ3 | |
| GSPSLWATASVSVEV | 431 | Q9UN74 | |
| VTVPDSITSWVATGF | 711 | Q6YHK3 | |
| TTTPWIIFNVASDTV | 171 | O60741 | |
| EITTVTDKTSPWSSV | 2076 | Q4AC94 | |
| VEFLWDPLSTSQTTS | 566 | P16383 | |
| VSKTSASSITLTWIP | 1391 | Q8TD84 | |
| PDTGVLTVSWERSTT | 1186 | P02751 | |
| LTVSWERSTTPDITG | 1191 | P02751 | |
| VTAVGTTLDSFWTEP | 706 | Q05707 | |
| TTLDSFWTEPATTIV | 711 | Q05707 | |
| SISWESSLFPALVQT | 486 | Q9Y5Q5 | |
| TWVFTPVTTEITSLD | 21 | Q9BS26 | |
| TVTWLSDSEVVRTPS | 116 | Q68D91 | |
| QASSSSVTITWTRVP | 696 | Q02388 | |
| ITPVNAWVSAVTLTS | 1651 | A6NE01 | |
| SSTLTSPIEASWVSS | 296 | Q92622 | |
| FTWTSSNETVVIVTT | 496 | Q5VU65 | |
| VVTETTATSVTLTWD | 326 | P10586 | |
| ISCTSPSSTSILVSW | 616 | P23468 | |
| TIASSSAPVSIWSPA | 141 | P32243 | |
| GLSLTVTVTFSPDEW | 116 | Q4G0U5 | |
| AILTSFSTIIWSSTP | 586 | Q9H195 | |
| QAIATSPESISISWS | 1096 | O60469 | |
| ELFSDTPTSVIISWQ | 2631 | O75445 | |
| SVWITISSTNFTSPV | 181 | P31641 | |
| WASLPTSVQVTISTA | 16 | Q8IYR2 | |
| VSSWILFSDGSVTPL | 701 | Q14DG7 | |
| LSWPSSLAVVAVSFS | 26 | Q6ZMQ8 | |
| VWSECTFFSTTPVLS | 401 | Q68DH5 | |
| TETLSTAPLASWVRS | 566 | Q8N3V7 | |
| RAVPSTFSWLDTVTV | 736 | Q06033 | |
| LCISSRSESVWTTTP | 31 | P0C851 | |
| TLTWIPDSFFSSLLS | 36 | Q8TBC3 | |
| VTLITVSTVSWFTEP | 531 | Q8WWX8 | |
| RTWAVSSVDTVLSPT | 1866 | Q9HCD6 | |
| LSVVSSAVPKTWVST | 266 | Q75T13 | |
| LPTSASEVATQTWTV | 206 | O95785 | |
| STVSTERCLSVLWPI | 121 | Q96LB1 | |
| VPAWVSSIVLTGTSE | 16 | Q68BL8 | |
| SALVSTNWLASTPSI | 731 | Q96KW2 | |
| TSIPSVSDSLTWREF | 236 | Q9UHE8 | |
| VTSIPSVSDSLTWRE | 216 | Q6NZ63 | |
| SSTEPSLLVSWFTRL | 536 | Q6P9H4 | |
| VSAELVPTSSWNISS | 36 | Q01973 | |
| WPTFISDIVGASRTS | 146 | O14980 | |
| TTGTAVETSVQTWTA | 1526 | Q96RL7 | |
| DWTKCSSFSPPTTVI | 201 | Q9NYG2 | |
| TVTDVTPNSVGLSWT | 1481 | P22105 | |
| TTIVTSGTSTVVCVW | 2946 | Q6ZS81 | |
| TWTTHFSPSVIIILV | 66 | Q6UWF5 | |
| SLSATPSLVTWTQVS | 751 | Q9BWH6 | |
| TTTWRPSSTTTIAGL | 156 | Q9UKJ0 | |
| VTTFSSPAAWLLVIA | 41 | Q13061 | |
| SPGLYTTWTLSTSSV | 451 | Q8TEC5 | |
| KTEPTTVTSATSAWA | 281 | A8MV65 | |
| PSLTSIAVSTWTAVA | 411 | O60806 | |
| LQFPSLRTTTTVSWC | 1636 | P31629 | |
| GISLCITSSVPWTAE | 121 | Q8WY98 | |
| ITDLESSTGLWPTIS | 461 | Q86Y07 | |
| SSTGLWPTISQFTLS | 466 | Q86Y07 | |
| AITTSLTTKWFSTPL | 46 | Q9NYU2 | |
| FDWTPVTSTDITVQV | 221 | Q6PL24 | |
| TGCTLWFATLTTTPT | 2896 | Q5THJ4 | |
| WFATLTTTPTRAALS | 2901 | Q5THJ4 |